Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
Open-market buys, last 90 days
$47,855
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$47,855. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. LEDERMAN SETH +$48K Chief Executive Officer 2 filings
Date Insider Transaction Shares Price Value Owned after
2026-05-12 Treco James Director Grant or award · Stock Option +22,700 22,700
2025-08-20 Treco James Director Purchase +250 $36.00 $9K 250
2025-05-13 Treco James Director Grant or award · Stock Option +10,000 10,000
2025-02-05 Treco James Director Other disposition −0.02 $0.30 $0 0
2024-05-23 Treco James Director Grant or award · Stock Option +104,621 104,621
2023-05-08 Treco James Director Grant or award · Stock Option +60,000 60,000
2022-05-09 Treco James Director Grant or award · Stock Option +2,131,500 2,131,500
2021-05-10 Treco James Director Grant or award · Stock Option +270,882 270,882
2020-08-31 Treco James Director Purchase +5,500 $0.89 $5K 10,000
2020-08-14 Treco James Director Purchase +4,500 $1.06 $5K 4,500
2020-05-04 Treco James Director Grant or award · Stock Option +112,500 112,500
2020-03-16 Treco James Director Grant or award · Stock Option +6,000 6,000
2019-05-06 Treco James Director Grant or award · Stock Option +30,000 30,000
2019-02-14 Treco James Director Grant or award · Stock Option +10,000 10,000

Page 1 of 1 · 14 trades